Company facts
- Industry
- Pharmaceutical Preparations
- Headquarters
- Bothell, Washington
- Most recent report
- 10-Q, filed Nov 9, 2026
- Incorporated
- Delaware
- Filings on record
- 464 filings
- On EDGAR
- CIK 1472012
- Fiscal year ends
- December
- Filer status
- Non-accelerated filer
Financials 8 of 25
News 8 of 84
Prospectuses and Registrations 8 of 33
- S-3ASR Automatic shelf registration Nov 9, 2026
- S-3ASR Automatic shelf registration Nov 9, 2026
- S-8 Registration statement for an employee plan Aug 11, 2026
- S-8 Registration statement for an employee plan Mar 3, 2026
- 424B5 Prospectus supplement for an offering Dec 17, 2025
- 424B5 Prospectus supplement for an offering Dec 15, 2025
- S-8 Registration statement for an employee plan Mar 19, 2025
- 424B5 Prospectus supplement for an offering Jan 30, 2025
Proxies 8 of 13
- DEFA14A Extra proxy material Apr 24, 2026
- DEF 14A Proxy statement for a shareholder vote Apr 24, 2026
- DEFA14A Extra proxy material Apr 24, 2025
- DEF 14A Proxy statement for a shareholder vote Apr 24, 2025
- DEFA14A Extra proxy material Apr 26, 2024
- DEF 14A Proxy statement for a shareholder vote Apr 26, 2024
- DEFA14A Extra proxy material Apr 20, 2023
- DEF 14A Proxy statement for a shareholder vote Apr 20, 2023
Ownership 8 of 257
- SCHEDULE 13G Large holder reported a passive stake Oct 30, 2026
- 4 Insider reported a trade Sep 15, 2026
- 144 Notice of a proposed sale of restricted stock Sep 11, 2026
- SCHEDULE 13G/A Large holder reported a passive stake, amended Aug 14, 2026
- SCHEDULE 13G/A Large holder reported a passive stake, amended Aug 14, 2026
- 4 Insider reported a trade Aug 12, 2026
- 144 Notice of a proposed sale of restricted stock Aug 12, 2026
- 4 Insider reported a trade Aug 10, 2026
Other 8 of 52
- ARS Annual report sent to shareholders Apr 24, 2026
- ARS Annual report sent to shareholders Apr 24, 2025
- ARS Annual report sent to shareholders Apr 26, 2024
- EFFECT Notice that a registration became effective Nov 27, 2023
- CORRESP Reply to SEC staff Nov 22, 2023
- UPLOAD Comment letter from SEC staff Nov 20, 2023
- 425 Sep 21, 2023
- EFFECT Notice that a registration became effective Aug 28, 2023
Everything here comes from Immunome Inc.'s own filings on SEC EDGAR. The filing list is rechecked every hour.